Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 105925
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.105925
Table 2 Postoperative outcomes

SPLA (n = 235)
MPLA (n = 235)
P value

95%CI

95%CI
Operation time (minute)a43.8 ± 15.8(41.8, 45.9)51.6 ± 18.7(49.2, 54.0)< 0.001
EBL (mL)b6.5 ± 7.8(5.4, 7.5)8.6 ± 8.3(7.5, 9.6)< 0.001
Drain insertion0.115
    No231 (98.3)224 (95.3)
    Yes4 (1.7)11 (4.7)
Complication0.315
    No202 (86.0)214 (91.1)
    Ileus2 (0.9)1 (0.4)
    Wound complication24 (10.2)18 (7.7)
    Intra-abdominal abscess6 (2.6)2 (0.9)
    Others1 (0.4)0 (0.0)
Postoperative pain score3.2 ± 1.3(3.1, 3.4)3.1 ± 1.3(3.0, 3.3)0.178
Antibiotics0.635
    No2 (0.9)2 (0.9)
    Cephalosporin191 (81.3)181 (77.0)
    Cephalosporin + Metronidazole41 (17.4)50 (21.3)
    Others1 (0.4)2 (0.9)
Hospital day (days)2.7 ± 1.3(2.6, 2.9)2.9 ± 1.3(2.7, 3.1)0.176
Readmission1.000
    No234 (99.6)234 (99.6)
    Yes1 (0.4)1 (0.4)